B2 | Protecting the environment from pharmaceuticals

Presentation: Pharmaceuticals in the environment: problems and solutions from a non-governmental point of view

Speaker: Erik Petersen, Board Member - Ökologischer Ärztebund - Doctors for the Environment (ISDE) Germany  

Erik Petersen, born in 1953, starting as a geologist, after 10 years in university and industry, changing to environmental health, first as a health practitioner, then 25 years as editor, writer and manager. The last years he has worked as a consultant in several research projects about biocides (sponsored by the Federal Environment Agency and the Ministry of Environment). At the moment, board member of the Ökologischer Ärztebund e.V. – Ecological Physicians Society (International Society of Doctors for the Environment ISDE  Germany) and member of the editorial board of the scientific journal Umwelt Medizin Gesellschaft (Environment Medicine-Society).

-----

Presentation: Ten years’ experience with the environmental risk assessment of human medicinal products

Speaker: Jason Snape, Senior Principal Scientist - AstraZeneca

Jason Snape is the Senior Principal Environmental Scientist within AstraZeneca and coordinates their Safety, Health and Environment (SHE) Research and Foresight programmes. Jason is an Environmental Microbiologist, Biochemist and Environmental Risk Assessor who provides scientific leadership on the pharmaceuticals in the environment (PIE) issue for AstraZeneca and the wider Pharmaceutical Industry.  Jason’s specific expertise and research is focused on (i) the environmental risk assessment of human medicinal products, (ii) the biodegradation and persistence of chemicals in the environment, (iii) determining the significance of antimicrobial resistance (AMR) in the environment as a source of resistance for clinical infection and the development of appropriate regulatory frameworks and guidance to improve environmental risk assessment for anti-infectives, and (iv) assessing the risks posed by medicinal products in emerging markets where use and exposure patterns differ due to the absence of adequate waste and drinking water treatment infrastructure. Jason is a member of the European Federation of Pharmaceutical Industry Associations (Efpia) PIE Task Force, its Governance Team, and Chairs its Environmental Risk Assessment Group. Jason also sits on the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) AMR Alliance Working Group for the Environment. Jason holds Honorary Professorship at the Universities of Warwick and Newcastle.

 

< Parallel Sessions 

Latest news

In an effort to reduce our paper consumption we are providing participants with smaller and more compact programmes that will be printed on reusable notebooks so participants can continue to use them after the conference.
As part of our efforts to make CleanMed Europe as sustainable and carbon neutral as possible, this year we are happy to provide participants with the opportunity to borrow a bike at no additional cost!
Co-Director of TEM, and founder of The Nordic Center for Sustainable Healthcare, Daniel Eriksson has attended several CleanMed Europe conferences and was even part of the organisational team for the 2012 edition in Malmö. We asked him a few questions about his CleanMed Europe experience...

Website by Studio Beam 2016